It is DNA-based test that, using a simple saliva simple, can identify certain genetic alterations associated to osteoarthritis progression. Dr. Vergés said that this tool could be used to identify and to give personalized treatment to severe OA cases and to assess the risks of prosthetic surgery, which in turn will lead to significant savings in health care expenditure.
This new tool will allow for the personalization of osteoarthritis treatments, and will reduce the need for prosthetic surgery. The studys results will be presented at the World Congress on Osteoarthritis, to be held in Barcelona, Spain, on April 25-29, 2012
This blog contains up-to-date information on osteoarthritis-treatment, publications, latest advances in research. It is also an online discussion area that encourages the participation of all healthcare professionals.It is hosted in the condroprotection.es website, a dedicated portal for healthcare professionals who specialize in osteoarthritis.
The Dysgen test uses a DNA chip and a blood sample to evaluate the genetic predisposition of dogs of the Labrador Retriever breed to develop hip dysplasia.
On March 15th, Bioiberica held at the Colegio Oficial de Veterinarios of Seville, Spain, a scientific session on interesting future trends in immunology and immunomodulation